Search - tctmd.com

Displaying 61 - 80 of 709

Sort: Relevancy | Date

Presentation TCT 2025

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Presenter: Santiago Garcia

October 25, 2025

Presentation TCT 2025

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

Presenter: Thomas Elie Modine

October 25, 2025

Presentation TCT 2025

TCT 1310: Emergent Tricuspid Valve-in-Valve TTVR After Evoque Ventricularization

Presenter: George Hanna

October 25, 2025

Presentation TCT 2025

TCT 224: Transcatheter Tricuspid Valve Replacement with Evoque after Tricuspid Transcatheter Edge-to-Edge Repair

Presenter: Dhiren Ray Rajagopal

October 25, 2025

Presentation TCT 2025

TCT 221: Global Insights from the TRICUS Registry: Real-World Outcomes with TricValve Bi-Caval Valve Therapy for Tricuspid Regurgitation

Presenter: Philipp Nikolai

October 25, 2025

Presentation TCT 2025

TCT 27: Acute Tricuspid Valve Annulus Remodeling After Transcatheter Edge-to-Edge Repair With TriClip

Presenter: Valeria Cammalleri

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Patient Considerations

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Who to Treat With TTVI?

Presenter: Suzanne Arnold

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Patient-Reported Outcomes are a True Measure of TTVI Value

Presenter: John Spertus

October 30, 2024

Presentation TCT 2024

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

Presenter: Ori Ben-Yehuda

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Presenter: Charles Davidson

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

Presenter: Brian Whisenant

October 30, 2024

Presentation TCT 2024

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

Presenter: Alexandra Lackey

October 30, 2024

Advertisement

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Clinical Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: 6-Month Results of the TRINITY Trial

TCT 1310: Emergent Tricuspid Valve-in-Valve TTVR After Evoque Ventricularization

TCT 224: Transcatheter Tricuspid Valve Replacement with Evoque after Tricuspid Transcatheter Edge-to-Edge Repair

TCT 221: Global Insights from the TRICUS Registry: Real-World Outcomes with TricValve Bi-Caval Valve Therapy for Tricuspid Regurgitation

TCT 27: Acute Tricuspid Valve Annulus Remodeling After Transcatheter Edge-to-Edge Repair With TriClip

What’s Going to Be Hot at TCT 2025

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Patient Considerations

Imaging Considerations

Who to Treat With TTVI?

How to Manage After TTVI?

Patient-Reported Outcomes are a True Measure of TTVI Value

CV Event Reduction is the Essential Criterion for Implementing New Device Therapies

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Real World TTVI Registries vs. Randomized Trials: Are the Outcomes Aligned?

TCT 984: Management of Right-Sided Vegetations With the AngioVac System: Single-Center Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content